We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRN
1426
Amarin Corp
AMRN
$284M
| $450K | ﹤0.01% |
1,049
+750
| +251% | +$285K |
|
1427
Invesco
IVZ
$13.3B
| $450K | ﹤0.01% |
24,990
-804
| -3% | -$13.7K |
|
1428
American Financial Group
AFG
$11.9B
| $448K | ﹤0.01% |
4,078
-191
| -4% | -$20.4K |
|
1429
Vanguard FTSE Europe ETF
VGK
$30B
| $447K | ﹤0.01% |
7,622
-193
| -2% | -$10.8K |
|
1430
PBF Energy
PBF
$7.29B
| $446K | ﹤0.01% |
14,212
+181
| +1% | +$5.57K |
|
1431
Simpson Manufacturing
SSD
$7.98B
| $446K | ﹤0.01% |
5,554
-5,985
| -52% | -$466K |
|
1432
Matthews International
MATW
$864M
| $444K | ﹤0.01% |
11,649
+338
| +3% | +$12.4K |
|
1433
SPX Corp
SPXC
$11B
| $443K | ﹤0.01% |
8,714
+667
| +8% | +$30.5K |
|
1434
Utah Medical Products
UTMD
$214M
| $440K | ﹤0.01% |
4,081
-5,097
| -56% | -$516K |
|
1435
Mesa Laboratories
MLAB
$539M
| $439K | ﹤0.01% |
1,759
+404
| +30% | +$94.6K |
|
1436
Keurig Dr Pepper
KDP
$40.4B
| $438K | ﹤0.01% |
15,119
+696
| +5% | +$20K |
|
1437
Atlantic Union Bankshares
AUB
$5.99B
| $437K | ﹤0.01% |
11,637
+363
| +3% | +$13.7K |
|
1438
BlackRock Municipal 2030 Target Term Trust
BTT
$1.43B
| $437K | ﹤0.01% |
18,066
| – | – |
|
|
STL
1439
DELISTED
Sterling Bancorp
STL
| $437K | ﹤0.01% |
20,711
-305
| -1% | -$6.22K |
|
1440
Chegg
CHGG
$108M
| $435K | ﹤0.01% |
11,478
-1,241
| -10% | -$43.4K |
|
1441
Dillards
DDS
$8.87B
| $434K | ﹤0.01% |
5,901
-2,693
| -31% | -$191K |
|
1442
Repligen
RGEN
$7.44B
| $434K | ﹤0.01% |
4,694
+803
| +21% | +$67.5K |
|
1443
Texas Capital Bancshares
TCBI
$4.31B
| $433K | ﹤0.01% |
7,629
-834
| -10% | -$47.5K |
|
1444
Sea Limited
SE
$61.2B
| $431K | ﹤0.01% |
10,718
+678
| +7% | +$22.8K |
|
1445
Ameris Bancorp
ABCB
$5.89B
| $429K | ﹤0.01% |
10,063
+4,057
| +68% | +$173K |
|
1446
Gray Television
GTN
$407M
| $429K | ﹤0.01% |
20,004
+11
| +0.1% | +$204 |
|
1447
NETGEAR
NTGR
$669M
| $429K | ﹤0.01% |
17,530
-1,156
| -6% | -$31.6K |
|
1448
Reaves Utility Income Fund
UTG
$3.69B
| $428K | ﹤0.01% |
11,555
+178
| +2% | +$6.52K |
|
1449
CVR Energy
CVI
$3.36B
| $426K | ﹤0.01% |
10,552
-260
| -2% | -$11.4K |
|
1450
Tetra Tech
TTEK
$8.23B
| $426K | ﹤0.01% |
24,690
-5,015
| -17% | -$86.9K |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.